Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fang

Showing results (1061-1070 of 1,281) with videos related to

Pageof 129
Sort By:
Journal of Clinical Microbiology|July 12, 2013
Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcomeVeronika Tchesnokova, Mariya Billig, Sujay Chattopadhyay, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 19, 2016
Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplantByung-Soo Ko, Stavros Drakos, Abdallah G Kfoury, et al.
JACC. Heart Failure|March 7, 2023
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HFDavid E Lanfear, Joyce N Njoroge, Kirkwood F Adams, et al.
American Journal of Hematology|June 28, 2001
Prevalence of HTLV-I-associated T-cell lymphomaB J Poiesz, L D Papsidero, G Ehrlich, et al.
Stroke|February 27, 2023
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopAlan S Go, Sana M Al-Khatib, Patrice Desvigne-Nickens, et al.
Journal of the American College of Cardiology|December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionMikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Nature Medicine|December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
JAMA Cardiology|January 31, 2024
Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF ScoreIosif Taleb, Christos P Kyriakopoulos, Robyn Fong, et al.
Pageof 129

Showing results (1061-1070 of 1,281) with videos related to

Sort By:
Pageof 129
Journal of Clinical Microbiology|July 12, 2013
Predictive diagnostics for Escherichia coli infections based on the clonal association of antimicrobial resistance and clinical outcomeVeronika Tchesnokova, Mariya Billig, Sujay Chattopadhyay, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|June 19, 2016
Immunologic effects of continuous-flow left ventricular assist devices before and after heart transplantByung-Soo Ko, Stavros Drakos, Abdallah G Kfoury, et al.
JACC. Heart Failure|March 7, 2023
Omecamtiv Mecarbil in Black Patients With Heart Failure and Reduced Ejection Fraction: Insights From GALACTIC-HFDavid E Lanfear, Joyce N Njoroge, Kirkwood F Adams, et al.
American Journal of Hematology|June 28, 2001
Prevalence of HTLV-I-associated T-cell lymphomaB J Poiesz, L D Papsidero, G Ehrlich, et al.
Stroke|February 27, 2023
Research Opportunities in Stroke Prevention for Atrial Fibrillation: A Report From a National Heart, Lung, and Blood Institute Virtual WorkshopAlan S Go, Sana M Al-Khatib, Patrice Desvigne-Nickens, et al.
Journal of the American College of Cardiology|December 16, 2022
Effect of Dapagliflozin on Health Status in Patients With Preserved or Mildly Reduced Ejection FractionMikhail N Kosiborod, Ankeet S Bhatt, Brian L Claggett, et al.
Nature Medicine|December 15, 2022
Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trialOrly Vardeny, James C Fang, Akshay S Desai, et al.
Journal of Cardiac Failure|April 3, 2012
Update on aldosterone antagonists use in heart failure with reduced left ventricular ejection fraction. Heart Failure Society of America Guidelines CommitteeJaved Butler, Justin A Ezekowitz, Sean P Collins, et al.
Journal of Cardiac Failure|February 4, 2012
Indications for cardiac resynchronization therapy: 2011 update from the Heart Failure Society of America Guideline CommitteeWilliam G Stevenson, Adrian F Hernandez, Peter E Carson, et al.
JAMA Cardiology|January 31, 2024
Machine Learning Multicenter Risk Model to Predict Right Ventricular Failure After Mechanical Circulatory Support: The STOP-RVF ScoreIosif Taleb, Christos P Kyriakopoulos, Robyn Fong, et al.
Pageof 129